journal article·2022-11

Experimental and theoretical characterization of Bi-based hydroxyapatites doped with Ce

Rebaz Obaid Kareem, Omer Kaygili, Tankut Ates, Niyazi Bulut, Suleyman Koytepe, Ali Kuruçay, Filiz Ercan, Ismail Ercan

Ceramics International· Volume 48· Issue 22
Publisher page

Abstract

This study deals with the theoretical and experimental characterizations of Bi-based hydroxyapatites (HAps) codoped with Ce. Five samples of Bi-based HAp (at a constant amount of 0.125 at.%) with additions of the Ce in various amounts (0, 0.125, 0.25, 0.375, and 0.500 at. %) were synthesized by using the wet chemical method. The prepared samples were investigated experimentally by X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier transform infrared (FTIR) spectroscopy, Raman spectroscopy, differential thermal analysis (DTA), thermogravimetric analysis (TGA), and vibrating sample magnetometer (VSM). All the samples were also modeled by using a density functional theory (DFT), and theoretical results were obtained. Both experimental and theoretical results showed that the lattice parameters and unit cell volume were significantly affected by Ce content. Calculated bandgap energy results of the samples gradually reduced from 4.6308 eV to 4.5299 eV. The bandgap decreased with increasing Ce content, and the densities of states (DOS) values were also affected by the amount of Ce. It was found that the sample doped with 0.500 at. % Ce showed the best biocompatibility among all the as-synthesized samples. The linear absorption coefficient increased with increasing amounts of Ce in all samples, while this parameter decreased with increasing photon energy. The density increases with the increasing Ce content ranging from 3.1615 g cm-3 to 3.1772 g cm- 3. Both crystallite size and crystallinity decreased gradually with the increasing amount of Ce. FTIR and Raman spectra confirm the formation of the HAp structure for all the samples.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Crystal Structures and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (81)

Show source-provided references
1. A comprehensive review on the preparation and application of calcium hydroxyapatite: a special focus on atomic doping methods for bone tissue engineering10.1016/j.ceramint.2021.07.100 ↗
2. 1993
3. Calcium orthophosphates in nature, biology and medicine10.3390/ma2020399 ↗
4. Substituted hydroxyapatites for biomedical applications: a review10.1016/j.ceramint.2015.03.316 ↗
5. Park · 2002
6. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis10.1002/jps.23824 ↗
7. Dorozhkin · 2012
8. Gallium-containing hydroxyapatite as a promising material for photocatalytic performance10.3390/min11121347 ↗
9. Strength characteristics of resorbable osteoconductive ceramics based on diphosphates of calcium and alkali metals10.1007/s11182-014-0160-7 ↗
10. Infrared studies of apatites. I. Vibrational assignments for calcium, strontium, and barium hydroxyapatites utilizing isotopic substitution10.1021/ic50131a039 ↗
11. A brief review on hydroxyapatite production and use in biomedicine10.1590/0366-69132019653742706 ↗
12. Preparation and solubility of hydroxyapatite10.6028/jres.072A.052 ↗
13. Phase purity of sol–gel-derived hydroxyapatite ceramic10.1016/S0142-9612(00)00448-8 ↗
14. A study of hydroxyapatite fibers prepared via sol–gel route10.1016/j.matlet.2004.06.030 ↗
15. Crystalline size, microstructure and biocompatibility of hydroxyapatite nanopowders by hydrolysis of calcium hydrogen phosphate dehydrate (DCPD)10.1016/j.ceramint.2014.10.135 ↗
16. Structural changes during the hydrolysis of dicalcium phosphate dihydrate to octacalcium phosphate and hydroxyapatite10.1134/S0020168515040147 ↗
17. Hydroxyapatite synthesized by a simplified hydrothermal method10.1016/0272-8842(95)00135-2 ↗
18. Growth and characterization of hydroxyapatite crystals by hydrothermal method10.1007/s10856-006-0070-5 ↗
19. Effect of precursor concentration and spray pyrolysis temperature upon hydroxyapatite particle size and density10.1002/jbm.b.33406 ↗
20. Particle formation of hydroxyapatite precursor containing two components in a spray pyrolysis process10.1007/s11705-014-1406-1 ↗
21. Preparation of hydroxyapatite via microemulsion route10.1016/S0021-9797(02)00233-3 ↗
22. Controllable synthesis of spherical hydroxyapatite nanoparticles using inverse microemulsion method10.1016/j.matchemphys.2016.08.021 ↗
23. Sonochemical synthesis of nano-hydroxyapatite using natural rubber latex as a templating agent10.1016/j.ceramint.2015.08.018 ↗
24. Synthesis and sintering of nanocrystalline hydroxyapatite powders by citric acid sol–gel combustion method10.1016/j.materresbull.2003.09.022 ↗
25. Synthesis, characterization, and morphological control of ZnTiO3 nanoparticles through sol-gel processes and its photocatalyst application10.1016/j.apt.2016.07.018 ↗
26. PCL-coated hydroxyapatite scaffold derived from cuttlefish bone: morphology, mechanical properties and bioactivity10.1016/j.msec.2013.09.036 ↗
27. Mechanochemical synthesis of nanocrystalline hydroxyapatite from Mercenaria clam shells and phosphoric acid10.1088/2057-1976/aa54f5 ↗
28. Synthesis of nanocrystalline hydroxyapatite by precipitation using hen's eggshell10.1016/j.ceramint.2012.11.050 ↗
29. In situ preparation of iron oxide nanoparticles in natural hydroxyapatite/chitosan matrix for bone tissue engineering application10.1016/j.ceramint.2014.10.153 ↗
30. Influence of Fe3O4 nanoparticles in hydroxyapatite scaffolds on proliferation of primary human fibroblast cells10.1007/s11665-016-2086-4 ↗
31. Porous hollow microspheres of amorphous calcium phosphate: soybean lecithin templated microwave-assisted hydrothermal synthesis and application in drug delivery10.1039/C4TB01862A ↗
32. A potential mechanism for amino acid-controlled crystal growth of hydroxyapatite10.1039/C5TB01036E ↗
33. Flower-like agglomerates of hydroxyapatite crystals formed on an egg-shell membrane10.1016/j.colsurfb.2010.10.006 ↗
34. Microwave assisted green synthesis of Hydroxyapatite nanorods using Moringa oleifera flower extract and its antimicrobial applications10.1016/j.ijvsm.2018.08.003 ↗
35. Cationic substitutions in hydroxyapatite: current status of the derived biofunctional effects and their in vitro interrogation methods10.3390/ma11112081 ↗
36. Ion-doped hydroxyapatite: an impasse or the road to follow?10.1016/j.ceramint.2020.02.001 ↗
37. Tricalcium phosphate ceramics doped with silver, copper, zinc, and iron (III) ions in concentrations of less than 0.5 wt.% for bone tissue regeneration10.1007/s12668-016-0386-7 ↗
38. Effect of silicon content on the surface morphology of silicon-substituted hydroxyapatite bio-ceramics treated by a hydrothermal vapor method10.1016/j.ceramint.2014.06.054 ↗
39. Synthesis and characterization of Ce-substituted hydroxyapatite by sol–gel method10.1016/j.msec.2014.05.024 ↗
40. Structural characterization of cerium-doped hydroxyapatite nanoparticles synthesized by an ultrasonic-assisted sol-gel technique10.1016/j.rinp.2018.08.012 ↗
41. Investigation of spin coating cerium-doped hydroxyapatite thin films with antifungal properties10.3390/coatings11040464 ↗
42. Cerium-doped hydroxyapatite nanoparticles synthesized by the co-precipitation method10.2298/JSC150824007C ↗
43. Development of cerium-doped hydroxyapatite coatings with antimicrobial properties for biomedical applications10.3390/coatings10060516 ↗
44. High temperature decomposition of cerium precursors to form ceria nanocrystal libraries for biological applications10.1021/cm200863q ↗
45. Preparation, characterization and antibacterial property of cerium substituted hydroxyapatite nanoparticles10.1016/S1002-0721(07)60455-4 ↗
46. Bismuth-the magic element10.1021/acs.inorgchem.0c00222 ↗
47. Biocoordination chemistry of bismuth: recent advances10.1016/j.ccr.2007.03.003 ↗
48. Green synthesis of bismuth based nanoparticles and its applications - a review
49. Bismuth(III) halide complexes of aromatic thiosemicarbazones: synthesis, structural characterization and biological evaluation10.1016/j.poly.2021.115388 ↗
50. Medical applications of metallic bismuth nanoparticles10.3390/pharmaceutics13111793 ↗
51. Novel bismuth‐based nanomaterials used for cancer diagnosis and therapy10.1002/chem.201801588 ↗
52. A review on the biodistribution, pharmacokinetics and toxicity of bismuth-based nanomaterials10.2147/IJN.S250001 ↗
53. Somatostatin-receptor-targeted alpha emitting 213Bi is therapeutically more effective than beta- emitting 177Lu in human pancreatic adenocarcinoma cells10.1016/j.nucmedbio.2006.11.006 ↗
54. Current and potential applications of bismuth-based drugs10.3390/molecules190915258 ↗
55. Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy via DNA damage enhancement10.1039/D1BM00157D ↗
56. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters10.1038/s41564-020-00802-x ↗
57. Repurposed therapeutic strategies towards COVID-19 potential targets based on genomics and protein structure remodeling
58. Upregulation of the renin–angiotensin system pathways and SARS-CoV-2 infection: the rationale for the administration of zinc-chelating agents in COVID-19 patients10.3390/cells10030506 ↗
59. SARS-Coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can Be inhibited by bismuth salts10.1007/s12250-020-00242-1 ↗
60. First principles methods using CASTEP10.1524/zkri.220.5.567.65075 ↗
61. Optoelectronics and defect levels in hydroxyapatite by first-principles10.1063/1.5025329 ↗
62. Ce/Sm co-doped hydroxyapatites: synthesis, characterization, and band structure calculation10.1007/s41779-020-00533-6 ↗
63. Rare-earth (Gd3+, Yb3+/Tm3+, Eu3+) co-doped hydroxyapatite as magnetic, up-conversion and down-conversion materials for multimodal imaging10.1038/s41598-019-52885-0 ↗
64. Investigation of the effects of Pr doping on the structural properties of hydroxyapatite: an experimental and theoretical study10.1007/s41779-020-00495-9 ↗
65. Effects of strontium-erbium co-doping on the structural properties of hydroxyapatite: an Experimental and theoretical study10.1016/j.ceramint.2020.03.194 ↗
66. Structural, spectroscopic, dielectric, and magnetic properties of Fe/Cu co-doped hydroxyapatites prepared by a wet-chemical method10.1016/j.physb.2021.413486 ↗
67. Experimental characterization and theoretical investigation of Ce/Yb co-doped hydroxyapatites10.1016/j.matchemphys.2021.125444 ↗
68. First-principles study of the biomineral hydroxyapatite10.1103/PhysRevB.84.134108 ↗
69. Density Of Elements Chart. https://www.angstromsciences.com/density-elements-chart. (accessed 19 December 2021).
70. Effect of gradual demineralization on the mineral fraction and mechanical properties of cortical bone10.1299/jbse.4.230 ↗
71. Erbium oxide and Cerium oxide-doped borosilicate glasses as radiation shielding material10.1080/10420150.2019.1674301 ↗
72. Densification behaviour and mechanisms of synthetic hydroxyapatites10.1016/S0955-2219(00)00154-0 ↗
73. Structural characterization, optical properties and in vitro bioactivity of mesoporous erbium-doped hydroxyapatite10.1016/j.jallcom.2015.05.064 ↗
74. Effect of Zn2+, Fe3+ and Cr3+ addition to hydroxyapatite for its application as an active constituent of sunscreens10.1088/1742-6596/249/1/012012 ↗
75. X-ray analysis by Williamson-Hall and size-strain plot methods of ZnO nanoparticles with fuel variation10.4236/wjnse.2014.41004 ↗
76. X-ray peak broadening studies of nanocrystalline hydroxyapatite by Williamson–Hall analysis10.1016/j.physb.2010.07.020 ↗
77. Synthesis of silver doped hydroxyapatite nanospheres using Ouzo effect10.2298/PAC1603169P ↗
78. Fabrication and characterization of novel biphasic calcium phosphate and nanosized hydroxyapatite derived from fish otoliths in different composition ratios
79. Antifungal applications of Ag-decorated hydroxyapatite nanoparticles10.1155/2013/174398 ↗
80. Iron (III) and manganese (II) substituted hydroxyapatite: characterization and cytotoxicity analysis10.1088/1742-6596/187/1/012024 ↗
81. Development of amperometric L-tyrosine based on Fe-doped hydroxyapatite nanoparticles10.1016/j.msec.2013.10.013 ↗